[Clinical experience with depot 1-(3-oxyphenyl)-2-ethylaminoethane in secondary chronic hypotensive syndromes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos
D010627:Phenethylamines; D010919:Placebos
Esperienze cliniche sull'azione del cloridrato di 1-(3-ossifenil)-1ossi-2-etilaminoetano retardo nelle sindromi ipotensive croniche secondaire.